Skip to main content
H.R. 1316 115th Congress House

Prescription Drug Price Transparency Act

Official title: To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Ad… Show full official titleShow less

Official title: To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Advantage program to further transparency of payment methodologies to pharmacies, and for other purposes.

Introduced: May 23, 2017 See on congress.gov
Health Administrative remediesConsumer affairsContracts and agencyGovernment employee pay, benefits, personnel management
More subjectsShow fewer subjects
Health care costs and insuranceHealth information and medical recordsInsurance industry and regulationMedical ethicsMedicareMilitary medicinePrescription drugsPublic contracts and procurementRetail and wholesale tradesRight of privacy
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 5, 2017
Referred to the Subcommittee on Military Personnel.
Mar 17, 2017
Referred to the Subcommittee on Health.
Mar 15, 2017
Referred to the Subcommittee on Health.
Mar 2, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 2, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 5, 2017

Referred to the Subcommittee on Military Personnel.

 Plain-English summary Congressional Research Service

Prescription Drug Price Transparency Act

This bill adds certain transparency requirements for pharmacy benefits managers under Medicare, Medicare Advantage, TRICARE, and the Federal Employees Health Benefits Program.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 7
 Cosponsors 56
All 56 Democratic 6 Republican 18
Poliquin, Bruce
· Sep 5, 2018
 D
Clarke, Yvette D.
New York · Jul 18, 2018
 R
DesJarlais, Scott
Tennessee · Jul 18, 2018
 D
Khanna, Ro
California · Jul 18, 2018
Posey, Bill
· Jul 18, 2018
Abraham, Ralph
· Jun 19, 2018
GOODLATTE, ROBERT
· Apr 26, 2018
 R
Higgins, Clay
Louisiana · Apr 17, 2018
Roby, Martha
· Apr 17, 2018
 D
Gonzalez, Vicente
Texas · Apr 13, 2018
King, Steve
· Apr 13, 2018
Herrera Beutler, Jaime
· Apr 11, 2018
 D
Beatty, Joyce
Ohio · Jan 11, 2018
Hartzler, Vicky
· Jan 11, 2018
Gallagher, Mike
· Jan 10, 2018
RYAN, TIM
· Jan 8, 2018
KING, PETER
· Oct 3, 2017
Rice, Kathleen
· Oct 3, 2017
 D
Raskin, Jamie
Maryland · Oct 2, 2017
 R
Cramer, Kevin
North Dakota · Sep 25, 2017
 R
Westerman, Bruce
Arkansas · Sep 13, 2017
 R
Newhouse, Dan
Washington · Sep 8, 2017
Young, David
· Jul 11, 2017
Hice, Jody
· Jun 26, 2017
Roe, David
· Jun 22, 2017
Byrne, Bradley
· Jun 20, 2017
 R
Marshall, Roger
Kansas · Jun 13, 2017
 R
Bacon, Don
Nebraska · Jun 12, 2017
Ferguson, A.
· Jun 12, 2017
 R
Griffith, H. Morgan
Virginia · Jun 8, 2017
Palazzo, Steven
· Jun 8, 2017
Harper, Gregg
· Jun 7, 2017
 R
Stefanik, Elise M.
New York · Jun 7, 2017
Vela, Filemon
· Jun 7, 2017
Barletta, Lou
· Jun 6, 2017
JONES, WALTER
· Jun 6, 2017
 R
Crawford, Eric A. "Rick"
Arkansas · May 23, 2017
 R
Rogers, Mike D.
Alabama · May 23, 2017
 R
Rouzer, David
North Carolina · May 23, 2017
CUMMINGS, ELIJAH
· May 16, 2017
Graves, Tom
· May 16, 2017
PETERSON, COLLIN
· May 16, 2017
Brooks, Mo
· May 2, 2017
 R
Scott, Austin
Georgia · Apr 28, 2017
 D
Welch, Peter
Vermont · Apr 28, 2017
 R
Aderholt, Robert B.
Alabama · Apr 25, 2017
 R
Allen, Rick W.
Georgia · Apr 25, 2017
 R
Wittman, Robert J.
Virginia · Mar 22, 2017
LANGEVIN, JAMES
· Mar 16, 2017
 R
Babin, Brian
Texas · Mar 2, 2017
Page 1 of 2 Next
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1316: Prescription Drug Price Transparency Act. 115th Congress. Open America. https://openamerica.io/bill/115-HR-1316/
MLA
"H.R. 1316: Prescription Drug Price Transparency Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-1316/.
Bluebook (legal)
H.R. 1316, 115th Cong. (2026), https://openamerica.io/bill/115-HR-1316/.
Markdown link
[H.R. 1316: Prescription Drug Price Transparency Act](https://openamerica.io/bill/115-HR-1316/)
Report a problem